Indiva Limited

lockPrivate Group

Our aim is to bring our family of global cannabis brands to Canadians, and as marijuana laws liberalize in Canada and internationally, Indiva will use its Canadian operations as a platform to open new markets for its products

people5 Members       (0)

Corporate Profile
Group Admins:
  • Thumb year end 2017
  • Thumb 8020 monitor 200 200  png
  • Thumb 8020 media relations
Request Membership


Indiva Limited

lockPrivateGroup

Our aim is to bring our family of global cannabis brands to Canadians, and as marijuana laws liberalize in Canada and......

people5 Members       (0)

Thumb 8020 media relations

Media Relations posted an update in INDIVA LIMITED

3 months

MI3 Financial Communications hosts Indiva Limited in Ottawa at their Dinner Series Investor forum


Thumb mi3 ottawa circuit

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva provides update on extraction operation at London facility in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, March 11, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXv:NDVA) (US:NDVAF) is pleased to provide an update on the design of its extraction facility in London, Ontario.



As previously announced, Indiva is working with Lucid Lab Group to design, construct and commission an ethanol-based extraction operation at Indiva's facility in London, Ontario.  Indiva is pleased to report that the design is now complete, and the result is annual expected biomass capacity of some 70 tonnes and resulting distillate capacity of over 4 million grams.  This capacity represents  a multiple of what Indiva will initially require for internal needs. The capital cost of the extraction equipment is estimated at US$1.4 million, is fully funded, and provides ample capacity to produce the wide spectrum of derivative and edible products licensed from Bhang and DeepCell, as well as Indiva branded product, subject to receipt of applicable regulatory approvals. This extraction capacity also opens the door to the possibility of producing distillate for licensed third parties through partnerships or joint-ventures which could add a substantial revenue to stream to Indiva's business.



"Indiva's plan to perform extraction on site in order to complement third party extraction services is founded in our commitment to provide high quality oils, concentrates and edibles to our patients and clients when permitted under Canadian law. We are delighted with the work Lucid Lab Group has completed, and the tremendous excess extraction capacity opens the door to several options to grow our revenue base and lower our unit costs," said Niel Marotta, President and CEO of Indiva. "We will be ready to offer edible products once regulations allow LPs to do so, and this facility gives Indiva room to grow its business in London for years to come."


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/11/c2910.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Pre-Rolls are Available Through the Ontario Cannabis Store in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, March 1, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) Is pleased to report that INDIVATM pre-rolls are now available through the Ontario Cannabis Store.  Indiva is currently offering two strains: an indica called LA Confidential and a sativa named Ghost Train Haze.  INDIVATM pre-rolls are hand-made, hand-weighed and crafted with care. The half-gram pre-rolls are currently available in convenient 2-packs in Ontario at www.ocs.ca.



"I am very proud of the team at Indiva.  I am inspired and grateful to work with such an amazing group of professionals who have dedicated themselves to a level of care in their craft which is clearly evident in the quality of Indiva's products," said Niel Marotta, President and CEO of Indiva.



About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/01/c1897.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Provides Update on Facility Expansion and Purchases Licensed Facility in London Ontario in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 20, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) is pleased to provide an update on its fully-funded expansion to 40,000 square feet at its facility in London, Ontario. 



The retrofit of 3 additional flower rooms is now complete and are currently undergoing standard cleaning and sanitization procedures.  The final video evidence package was submitted to Health Canada on January 21st. Once licensed by Health Canada, these 3 new rooms will immediately be populated with plants currently growing in Indiva's facility, and increase Indiva's annual dry flower capacity to 1,000kg.  By the end of Q2, Indiva expects that dry flower capacity will increase to some 3,000kg annually with the licensing of 5 additional flower rooms.



The Company is also pleased to announce the purchase of its facility at 1050 Hargrieve Rd. in London, Ontario pursuant to an agreement of purchase and sale dated November 28, 2018.  The strategic decision to purchase the property reflects the fact that licenses granted under the Cannabis Act are tied to a specific address. With the $5.55 million cash purchase of the property, Indiva now has secured long-term certainty for the home of the organization's operations.  Further, by owning the property it allows Indiva a greater ability for potential debt financing options in the future and has streamlined the process behind the planned creation of the Indiva farmgate store (subject to AGCO approval).


"Indiva's expansion is on track, and we are excited to now fully own the property which grows, and will manufacture, some of the highest quality cannabis and cannabis derivative products on the market," said Niel Marotta, President and CEO of Indiva.


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future licensing approvals, future expansion of growing capacity, TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/20/c6823.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Limited - Press Release Correction in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 15, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) announces a correction to its press release entitled "BNN BLOOMBERG IDENTIFIES INDIVA AS RAPIDLY GROWING IN THE CANNABIS SECTOR" issued today.



The Company wishes to clarify the Company will be featured on an upcoming episode of Business Television (BTV), a program aired on BNN Bloomberg, and has not been endorsed or otherwise identified by BNN Bloomberg.



BTV is a half-hour weekly investment program, which profiles emerging companies across Canada and the US to bring investors information for their portfolio. With Hosts Taylor Thoen and Jessica Katrichak, BTV interviews experts, top analysts, plus features companies at their location giving investors an insightful business perspective.


BTV BROADCAST TIMES:


CANADA: BNN Bloomberg – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST


Bell Express Vu – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST


Air Canada: TV Seatback: Business Channel


U.S. National:


Biz Television Network – Sun Feb. 24 @ 10:00pm & 4:30pm PST, Sat Feb. 2 @ 9:00pm PST


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/15/c2343.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva announces initial supply agreement with the Ontario Cannabis Store in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 8, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSX:NDVA) (US:NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation ("OCRC"), doing business as the Ontario Cannabis Store ("OCS").



This initial partnership will consist of two strains of pre-rolls, manufactured and shipped with care from Indiva's London, Ontario facility. The products will be available on OCS.ca and to OCS Wholesale clients starting in April 2019.



"We are thrilled to be one of the first licensed producers that will have products on OCS shelves in time for the grand opening of all Ontario stores April 1st," said Niel Marotta, President and CEO of Indiva. "I'm very thankful for our team's hard work in getting Indiva to this milestone."


About Indiva
Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.   


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited



View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/08/c2465.html



Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media in INDIVA LIMITED

SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering INDIVA Limited (TSX-V:NDVA). Indiva is a licensed supplier of high quality, medical-grade cannabis located in London, Ontario; recognizing that many consumers are looking for alternatives to smoking, the company made a number of exciting strategic moves throughout 2018 to diversify its brand. The company went public in December of 2017, currently has $24 million on the balance sheet with a $46 million market cap, and its fully-funded facility expansion project is nearing completion.


Click here to see the company’s investor presentation


Indiva stresses quality over quantity, and intends to become a global brand recognized for high quality cannabis products and excellent client services. The INDIVA brand includes pre-rolls, capsules, and accessories, and the company has developed a range of other products in order to hit the ground running when Canada’s cannabis regulations are further liberalized later this year.


Indiva’s London facility includes four state of the art grow rooms and the $13.7 million, fully-funded, expansion currently underway will result in a 40,000 square foot facility with up to eight more rooms for cultivation, extraction, product manufacturing, and even a retail space. Indiva’s cannabis flower is produced using aeroponics, a soil-less process in which plant roots are suspended in air and misted with all the nutrients they need, producing larger yields and a much cleaner product while being environmentally friendly.


Bhang’s Award-Winning Offering


In April of 2018, the company announced a 50/50 joint venture with Nevada-based Bhang Corporation, an award-winning producer of cannabis and CBD edibles and concentrates, which will be managed by Indiva and enable the manufacture and sale of Bhang products in Canada, as well as the export of its products internationally. Through the agreement, Indiva gained exclusive access to Bhang’s portfolio of products including the most awarded line of chocolate bars in the world, gummies, oral sprays, isolates, vapes and vape cartridges, and a range of accessories. The company also announced a 4.9% stake in Bhang, giving it its first entry into the legal US adult-use market.


Click here to see the company’s investor presentation


“Flexible Edibles”


Later that same month, Indiva announced the company has a 14% stake in and exclusive license agreement with DeepCell Industries - a Seattle-based technology development company focusing on material science, microfluidics, and cannabinoid molecule discoveries – giving it the exclusive right to manufacture and market DeepCell’s entire line of innovative products produced through its patented Crystal Fusion technology. Crystal Fusion mechanically fuses cannabinoids with sugar or salt, producing a “flexible edible” with which consumers can infuse their food and beverages with flavour as well as THC or CBD. The resulting products are sold as Ruby Cannabis Sugar and Ruby Cannabis Salt.


All Bhang products and Ruby sugars and salts will be cross-branded in Canada - “Powered By INDIVA”.


MediPharm Extraction 


In September, Indiva entered into a Cannabis Concentrate Program Agreement with MediPharm Labs, Inc. a pioneer in the cannabis industry and the first Canadian licensed producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. Indiva will supply dried cannabis to MediPharm, which it will use to produce cannabis oil. MediPharm may provide cannabis oil to Indiva or to other licensed producers at the direction of Indiva, which may release the cannabis extract for use by MediPharm. The program was established at no capital cost to Indiva, but MediPharm will charge the company processing fees for the oil produced, and the revenue on sales of oil by MediPharm will be shared between MediPharm and Indiva.


Click here to see the company’s investor presentation


Denmark, Gateway To European Cannabis Market


At the end of November, Indiva announced it had signed a non-binding letter of intent with AEssense Europe for the acquisition of 100% of a medical cannabis cultivation and handling license in Denmark. AEssense Europe received its license – one of only twelve granted - from the Danish Medicines Agency on January 12, 2018. The Danish Parliament legalized medical cannabis through a unanimous vote on January 1, 2018, and is poised to become one of Europe’s leading producers of medical cannabis. Denmark will serve as the company’s gateway to the European market, which is predicted to be larger than the US and Canadian markets combined.


Indiva will pursue the cultivation and worldwide distribution of EU-GMP certified medical cannabis and cannabis-derived products, and intends to incorporate a wholly-owned subsidiary, Indiva Europe, to finance and manage the European operations. In collaboration with AEssense, Indiva Europe plans to construct an indoor grow facility based on AEssense's proprietary AEtrium fully automated aeroponic grow platform, enabling Indiva to produce consistent, ultra-clean, premium pharmaceutical quality cannabis product compliant with GACP and EU-GMP standards. Sites have been identified to begin construction of a 1,000 square foot research lab as part of the production facility, with ample room for scaled expansion. Indiva will have the exclusive right to all cannabis-related production, and will leverage the Denmark license for the importation of EU-GMP cannabis into the Danish and European markets.


Community Engagement


Indiva is a community-minded company, helping first responders and veterans, chronic illness support organizations, and other community initiatives, and gives twenty cents from every gram of Indiva-branded flower and oil product to support mental and physical health initiatives and organizations across Canada. The company’s Master Grower, Pete Young, is well known for his cannabis activism, founded the London Compassion Society in the mid-90’s, and is a respected advocate of patients’ rights.


Indiva is worth watching as the company continues to diversify from a supplier of medical cannabis to a manufacturer and retailer of high margin cannabis-derived and pre-packaged products, partner with innovative companies like Bhang and Deepcell, and especially as its reach into larger foreign markets expands.


For more information, please visit: https://www.indiva.com/


Please follow the link to read the full article: https://www.cannabisfn.com/indiva-shapes-strong-brand-identity-in-canada-eyes-emerging-european-market/


About CFN Media


For Visitors and Viewers


CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.


For Cannabis Businesses & Companies


CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.


Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.


Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.


Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany


Disclaimer


CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  


The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensationhttp://www.cannabisfn.com/legal-disclaimer/

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Seattle-Based Lucid Lab Group Tapped to Design Indiva's Extraction Facility in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Jan. 31, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA.V) (US:NDVAF) has further solidified its commitment to the upcoming cannabis derivatives and edibles market by hiring Lucid Lab Group to design the Company's planned extraction facility.



The facility, which is planned for Q2 2019, will be the hub of oil manufacturing and product innovation for all of Indiva's related cannabis products, including tinctures and gel capsules, as well as licensed products such as Bhang Chocolate, Ruby Sugar and Ruby Chewable Gems.



Lucid Lab Group are experts in the design and operation of cannabis extraction facilities. They are based in Seattle, Washington, the home base of another Indiva partner, DeepCell Industries. DeepCell creates cannabis-infused products using their patented Crystal Fusion technology, and have also worked with Lucid to produce cannabis oil for their products.


"We are very excited to work with Lucid given their expertise in this area, as well as their past history with one of our preferred partners and licensor DeepCell," said Niel Marotta, Indiva's President and CEO, "our goal is to be prepared to serve the legal edibles market with high quality, innovative and award winning products."


About Indiva


Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.   


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/31/c7061.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Announces Investment in RetailGo Inc. in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Jan. 22, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) is pleased to announce it has completed a 9.9% equity investment into RetailGo Inc (or "RGI").  Indiva will contribute leases for 10 proposed retail locations in Ontario, and will receive a 5-year promissory note in the amount of $730,000, plus an additional $300,000 to be repaid separately, representing funds committed to date.



RetailGo Inc will be managed by Koby Smutylo, who has resigned from his position as COO and Director of Indiva, effective immediately, in order to focus his efforts on RGI.  Koby is a co-founder of Indiva.  The Indiva board would like to thank Koby for his efforts and contribution, and wish him well in his new endeavour.



About Indiva
Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/22/c6026.html



Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!

Indiva Limited

lockPrivate Group

Our aim is to bring our family of global cannabis brands to Canadians, and as marijuana laws liberalize in Canada and internationally, Indiva will use its Canadian operations as a platform to open new markets for its products

people5 Members       (0)

Corporate Profile
Group Admins:
  • Thumb year end 2017
  • Thumb 8020 monitor 200 200  png
  • Thumb 8020 media relations
Request Membership


Indiva Limited

lockPrivateGroup

Our aim is to bring our family of global cannabis brands to Canadians, and as marijuana laws liberalize in Canada and......

people5 Members       (0)

Thumb 8020 media relations

Media Relations posted an update in INDIVA LIMITED

3 months

MI3 Financial Communications hosts Indiva Limited in Ottawa at their Dinner Series Investor forum


Thumb mi3 ottawa circuit

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva provides update on extraction operation at London facility in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, March 11, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXv:NDVA) (US:NDVAF) is pleased to provide an update on the design of its extraction facility in London, Ontario.



As previously announced, Indiva is working with Lucid Lab Group to design, construct and commission an ethanol-based extraction operation at Indiva's facility in London, Ontario.  Indiva is pleased to report that the design is now complete, and the result is annual expected biomass capacity of some 70 tonnes and resulting distillate capacity of over 4 million grams.  This capacity represents  a multiple of what Indiva will initially require for internal needs. The capital cost of the extraction equipment is estimated at US$1.4 million, is fully funded, and provides ample capacity to produce the wide spectrum of derivative and edible products licensed from Bhang and DeepCell, as well as Indiva branded product, subject to receipt of applicable regulatory approvals. This extraction capacity also opens the door to the possibility of producing distillate for licensed third parties through partnerships or joint-ventures which could add a substantial revenue to stream to Indiva's business.



"Indiva's plan to perform extraction on site in order to complement third party extraction services is founded in our commitment to provide high quality oils, concentrates and edibles to our patients and clients when permitted under Canadian law. We are delighted with the work Lucid Lab Group has completed, and the tremendous excess extraction capacity opens the door to several options to grow our revenue base and lower our unit costs," said Niel Marotta, President and CEO of Indiva. "We will be ready to offer edible products once regulations allow LPs to do so, and this facility gives Indiva room to grow its business in London for years to come."


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/11/c2910.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Pre-Rolls are Available Through the Ontario Cannabis Store in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, March 1, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) Is pleased to report that INDIVATM pre-rolls are now available through the Ontario Cannabis Store.  Indiva is currently offering two strains: an indica called LA Confidential and a sativa named Ghost Train Haze.  INDIVATM pre-rolls are hand-made, hand-weighed and crafted with care. The half-gram pre-rolls are currently available in convenient 2-packs in Ontario at www.ocs.ca.



"I am very proud of the team at Indiva.  I am inspired and grateful to work with such an amazing group of professionals who have dedicated themselves to a level of care in their craft which is clearly evident in the quality of Indiva's products," said Niel Marotta, President and CEO of Indiva.



About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/01/c1897.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Provides Update on Facility Expansion and Purchases Licensed Facility in London Ontario in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 20, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) is pleased to provide an update on its fully-funded expansion to 40,000 square feet at its facility in London, Ontario. 



The retrofit of 3 additional flower rooms is now complete and are currently undergoing standard cleaning and sanitization procedures.  The final video evidence package was submitted to Health Canada on January 21st. Once licensed by Health Canada, these 3 new rooms will immediately be populated with plants currently growing in Indiva's facility, and increase Indiva's annual dry flower capacity to 1,000kg.  By the end of Q2, Indiva expects that dry flower capacity will increase to some 3,000kg annually with the licensing of 5 additional flower rooms.



The Company is also pleased to announce the purchase of its facility at 1050 Hargrieve Rd. in London, Ontario pursuant to an agreement of purchase and sale dated November 28, 2018.  The strategic decision to purchase the property reflects the fact that licenses granted under the Cannabis Act are tied to a specific address. With the $5.55 million cash purchase of the property, Indiva now has secured long-term certainty for the home of the organization's operations.  Further, by owning the property it allows Indiva a greater ability for potential debt financing options in the future and has streamlined the process behind the planned creation of the Indiva farmgate store (subject to AGCO approval).


"Indiva's expansion is on track, and we are excited to now fully own the property which grows, and will manufacture, some of the highest quality cannabis and cannabis derivative products on the market," said Niel Marotta, President and CEO of Indiva.


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future licensing approvals, future expansion of growing capacity, TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/20/c6823.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Limited - Press Release Correction in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 15, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) announces a correction to its press release entitled "BNN BLOOMBERG IDENTIFIES INDIVA AS RAPIDLY GROWING IN THE CANNABIS SECTOR" issued today.



The Company wishes to clarify the Company will be featured on an upcoming episode of Business Television (BTV), a program aired on BNN Bloomberg, and has not been endorsed or otherwise identified by BNN Bloomberg.



BTV is a half-hour weekly investment program, which profiles emerging companies across Canada and the US to bring investors information for their portfolio. With Hosts Taylor Thoen and Jessica Katrichak, BTV interviews experts, top analysts, plus features companies at their location giving investors an insightful business perspective.


BTV BROADCAST TIMES:


CANADA: BNN Bloomberg – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST


Bell Express Vu – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST


Air Canada: TV Seatback: Business Channel


U.S. National:


Biz Television Network – Sun Feb. 24 @ 10:00pm & 4:30pm PST, Sat Feb. 2 @ 9:00pm PST


About Indiva
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva's wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/15/c2343.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva announces initial supply agreement with the Ontario Cannabis Store in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Feb. 8, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSX:NDVA) (US:NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation ("OCRC"), doing business as the Ontario Cannabis Store ("OCS").



This initial partnership will consist of two strains of pre-rolls, manufactured and shipped with care from Indiva's London, Ontario facility. The products will be available on OCS.ca and to OCS Wholesale clients starting in April 2019.



"We are thrilled to be one of the first licensed producers that will have products on OCS shelves in time for the grand opening of all Ontario stores April 1st," said Niel Marotta, President and CEO of Indiva. "I'm very thankful for our team's hard work in getting Indiva to this milestone."


About Indiva
Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.   


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited



View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2019/08/c2465.html



Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media in INDIVA LIMITED

SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering INDIVA Limited (TSX-V:NDVA). Indiva is a licensed supplier of high quality, medical-grade cannabis located in London, Ontario; recognizing that many consumers are looking for alternatives to smoking, the company made a number of exciting strategic moves throughout 2018 to diversify its brand. The company went public in December of 2017, currently has $24 million on the balance sheet with a $46 million market cap, and its fully-funded facility expansion project is nearing completion.


Click here to see the company’s investor presentation


Indiva stresses quality over quantity, and intends to become a global brand recognized for high quality cannabis products and excellent client services. The INDIVA brand includes pre-rolls, capsules, and accessories, and the company has developed a range of other products in order to hit the ground running when Canada’s cannabis regulations are further liberalized later this year.


Indiva’s London facility includes four state of the art grow rooms and the $13.7 million, fully-funded, expansion currently underway will result in a 40,000 square foot facility with up to eight more rooms for cultivation, extraction, product manufacturing, and even a retail space. Indiva’s cannabis flower is produced using aeroponics, a soil-less process in which plant roots are suspended in air and misted with all the nutrients they need, producing larger yields and a much cleaner product while being environmentally friendly.


Bhang’s Award-Winning Offering


In April of 2018, the company announced a 50/50 joint venture with Nevada-based Bhang Corporation, an award-winning producer of cannabis and CBD edibles and concentrates, which will be managed by Indiva and enable the manufacture and sale of Bhang products in Canada, as well as the export of its products internationally. Through the agreement, Indiva gained exclusive access to Bhang’s portfolio of products including the most awarded line of chocolate bars in the world, gummies, oral sprays, isolates, vapes and vape cartridges, and a range of accessories. The company also announced a 4.9% stake in Bhang, giving it its first entry into the legal US adult-use market.


Click here to see the company’s investor presentation


“Flexible Edibles”


Later that same month, Indiva announced the company has a 14% stake in and exclusive license agreement with DeepCell Industries - a Seattle-based technology development company focusing on material science, microfluidics, and cannabinoid molecule discoveries – giving it the exclusive right to manufacture and market DeepCell’s entire line of innovative products produced through its patented Crystal Fusion technology. Crystal Fusion mechanically fuses cannabinoids with sugar or salt, producing a “flexible edible” with which consumers can infuse their food and beverages with flavour as well as THC or CBD. The resulting products are sold as Ruby Cannabis Sugar and Ruby Cannabis Salt.


All Bhang products and Ruby sugars and salts will be cross-branded in Canada - “Powered By INDIVA”.


MediPharm Extraction 


In September, Indiva entered into a Cannabis Concentrate Program Agreement with MediPharm Labs, Inc. a pioneer in the cannabis industry and the first Canadian licensed producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. Indiva will supply dried cannabis to MediPharm, which it will use to produce cannabis oil. MediPharm may provide cannabis oil to Indiva or to other licensed producers at the direction of Indiva, which may release the cannabis extract for use by MediPharm. The program was established at no capital cost to Indiva, but MediPharm will charge the company processing fees for the oil produced, and the revenue on sales of oil by MediPharm will be shared between MediPharm and Indiva.


Click here to see the company’s investor presentation


Denmark, Gateway To European Cannabis Market


At the end of November, Indiva announced it had signed a non-binding letter of intent with AEssense Europe for the acquisition of 100% of a medical cannabis cultivation and handling license in Denmark. AEssense Europe received its license – one of only twelve granted - from the Danish Medicines Agency on January 12, 2018. The Danish Parliament legalized medical cannabis through a unanimous vote on January 1, 2018, and is poised to become one of Europe’s leading producers of medical cannabis. Denmark will serve as the company’s gateway to the European market, which is predicted to be larger than the US and Canadian markets combined.


Indiva will pursue the cultivation and worldwide distribution of EU-GMP certified medical cannabis and cannabis-derived products, and intends to incorporate a wholly-owned subsidiary, Indiva Europe, to finance and manage the European operations. In collaboration with AEssense, Indiva Europe plans to construct an indoor grow facility based on AEssense's proprietary AEtrium fully automated aeroponic grow platform, enabling Indiva to produce consistent, ultra-clean, premium pharmaceutical quality cannabis product compliant with GACP and EU-GMP standards. Sites have been identified to begin construction of a 1,000 square foot research lab as part of the production facility, with ample room for scaled expansion. Indiva will have the exclusive right to all cannabis-related production, and will leverage the Denmark license for the importation of EU-GMP cannabis into the Danish and European markets.


Community Engagement


Indiva is a community-minded company, helping first responders and veterans, chronic illness support organizations, and other community initiatives, and gives twenty cents from every gram of Indiva-branded flower and oil product to support mental and physical health initiatives and organizations across Canada. The company’s Master Grower, Pete Young, is well known for his cannabis activism, founded the London Compassion Society in the mid-90’s, and is a respected advocate of patients’ rights.


Indiva is worth watching as the company continues to diversify from a supplier of medical cannabis to a manufacturer and retailer of high margin cannabis-derived and pre-packaged products, partner with innovative companies like Bhang and Deepcell, and especially as its reach into larger foreign markets expands.


For more information, please visit: https://www.indiva.com/


Please follow the link to read the full article: https://www.cannabisfn.com/indiva-shapes-strong-brand-identity-in-canada-eyes-emerging-european-market/


About CFN Media


For Visitors and Viewers


CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.


For Cannabis Businesses & Companies


CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.


Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.


Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.


Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany


Disclaimer


CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  


The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensationhttp://www.cannabisfn.com/legal-disclaimer/

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Seattle-Based Lucid Lab Group Tapped to Design Indiva's Extraction Facility in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Jan. 31, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA.V) (US:NDVAF) has further solidified its commitment to the upcoming cannabis derivatives and edibles market by hiring Lucid Lab Group to design the Company's planned extraction facility.



The facility, which is planned for Q2 2019, will be the hub of oil manufacturing and product innovation for all of Indiva's related cannabis products, including tinctures and gel capsules, as well as licensed products such as Bhang Chocolate, Ruby Sugar and Ruby Chewable Gems.



Lucid Lab Group are experts in the design and operation of cannabis extraction facilities. They are based in Seattle, Washington, the home base of another Indiva partner, DeepCell Industries. DeepCell creates cannabis-infused products using their patented Crystal Fusion technology, and have also worked with Lucid to produce cannabis oil for their products.


"We are very excited to work with Lucid given their expertise in this area, as well as their past history with one of our preferred partners and licensor DeepCell," said Niel Marotta, Indiva's President and CEO, "our goal is to be prepared to serve the legal edibles market with high quality, innovative and award winning products."


About Indiva


Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.   


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/31/c7061.html

Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!
Thumb 8020 monitor 200 200  png

8020 Admin

3 months

8020 Admin posted a press release Indiva Announces Investment in RetailGo Inc. in INDIVA LIMITED


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

LONDON, ON, Jan. 22, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) (US:NDVAF) is pleased to announce it has completed a 9.9% equity investment into RetailGo Inc (or "RGI").  Indiva will contribute leases for 10 proposed retail locations in Ontario, and will receive a 5-year promissory note in the amount of $730,000, plus an additional $300,000 to be repaid separately, representing funds committed to date.



RetailGo Inc will be managed by Koby Smutylo, who has resigned from his position as COO and Director of Indiva, effective immediately, in order to focus his efforts on RGI.  Koby is a co-founder of Indiva.  The Indiva board would like to thank Koby for his efforts and contribution, and wish him well in his new endeavour.



About Indiva
Indiva's wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva's mission is to offer cannabis products that have a positive impact, improving lives and communities.


Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.


DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


 

SOURCE Indiva Limited


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/22/c6026.html



Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com ; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com 

!